Dimitrios Mathios, MD

Research Interests

Brain tumors are devastating for the individuals affected and present a challenge for the doctors taking care of them. Despite the technological and surgical advancements, many patients succumb to their disease and others have serious side effects related to their treatments. With my expertise in Cancer Immunology, Genetics and Epigenetics, I have applied these tools towards the development of treatments before they become symptomatic, and at a point when they are easily resectable or curable with other treatments that could lead to improved outcomes. The Molecular Neuro-oncology lab is focused on developing genomic and epigenomic approaches for the development of liquid biopsy assays for non-invasive detection of brain tumors. The work performed is multidisciplinary and includes physicians, molecular biologists, and bioinformaticians.